FUT3 and cancer: However, it has been demonstrated that the antigen is hardly detectable in patients with early stages of cancer and that, in addition to the occurrence of false-positive results in some diseases, false-negative results are also unavoidable [50], which are caused by the absence of the Le gene-dependent Le enzyme in patients with le/le genotypes [32,33].